FDA Approves Wyeth's New Antidepressant Pristiq, Planned Successor ... - Trading Markets (press release)
Effexor XR, Wyeth's extended-release depression drug, last year posted $3.8 billion, 17 percent of its total revenue. Cheaper generic competition is ...